New & Notable
FDA investigates E. coli outbreak in organic carrots
The FDA is investigating an E. coli outbreak linked to several brands of organic carrots that were recalled by Grimmway Farms for contamination with Shiga toxin-producing E. coli.
Over half of Americans won't get the new COVID-19 vaccine
Although over half of Americans do not plan to get the new COVID-19 vaccine for a range of reasons, perceptions vary based on political affiliation, age and race.
Revolutionizing women's health technology through innovation
As more scientists and innovators work toward addressing the gaps in women's healthcare, women's health technology and the ongoing innovation in tech will be critical tools.
Adopting plant-based plastics to create single-use systems
The biopharmaceutical industry is adopting plant-based, single-use plastic systems to reduce its environmental impact and meet industry standards for safety and compliance.
Insights
Insights is the research division of Xtelligent Healthcare Media. Our work aims to leverage Xtelligent’s diverse readership of healthcare professionals across various sectors of the industry to understand real-world challenges and identify effective solutions.
Access All Reports
Healthcare Strategies: A Podcast
-
A podcast for healthcare professionals seeking solutions to today's and tomorrow's top challenges. Hosted by the editors of Xtelligent Healthcare Media, this podcast series focuses on real-world use cases that are leading to tangible improvements in care quality, outcomes, and cost.
Guests from leading provider, payer, government, and other organizations share their approaches to transforming healthcare in a meaningful and lasting way.
View All Episodes
Latest News
-
WHO, CDC report a 20% rise in global measles cases
The WHO and CDC emphasize the need for greater measles surveillance and targeted vaccination efforts to address the 20% rise in global measles cases from 2022 to 2023.
-
CDC estimates a national diabetes prevalence of nearly 16%
A data brief from the CDC focused on the national diabetes prevalence across the U.S. estimates that 16% of adults in the U.S. have diabetes, with approximately 4.5% being undiagnosed.
-
Vaccines are key in cutting antimicrobial resistance, costs
WHO's report emphasizes vaccines in fighting antimicrobial resistance. Broader vaccine access could save thousands of lives, reduce antibiotic use and cut global healthcare costs.
-
Iowa resident dies of suspected Lassa fever after travel
The investigation into the death of an Iowa resident suspected to have contracted Lassa fever in West Africa might identify the ninth case of Lassa virus in the U.S. since 1969.
-
TreeHouse Foods expands recall of waffles, pancakes
TreeHouse Foods expands its recall of waffles and pancakes from major retailers, like Walmart, Target, Aldi, Dollar General, Kroger, Publix, Whole Foods, Trader Joe's and more.
-
Hurricane Helene triggers dialysis and IV fluid shortage
Following Hurricane Helene, damages to a manufacturing plant in North Carolina and subsequent nationwide IV fluid shortages have forced manufacturers to mobilize global networks.
Features
-
Employing ML to boost pharmacokinetics in drug development
Machine learning revolutionizes pharmacokinetics by accurately predicting drug behavior and optimizing dosages, streamlining drug development and regulatory approval.
-
Exploring biomarker strategies in rare disease therapeutics
Innovative biomarker strategies and regulatory flexibility from the FDA are helping to streamline rare disease therapy development, addressing patient needs more effectively.
-
AMPEL develops a blood test for cardiovascular disease
Armie Grammer, AMPEL's co-founder, president, and chief scientific officer of AMPEL BioSolutions, explains the company's CardioGENE blood test for cardiovascular disease risk.
-
Role of advanced modeling and virtual data in drug approvals
Advanced modeling and virtual data help biopharma companies design efficient, ethical and cost-effective trials to accelerate drug development and regulatory approvals.